- Tytuł:
- 101 - Clinical-Risk Factors that Influence an Optimal Hypomethylating Agents Treatment in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
- Autorzy:
- Źródło:
- In Leukemia Research April 2017 55 Supplement 1:S64-S64
Czasopismo naukowe